- Home
- QURE vs CMP Comparison
QURE vs CMP Comparison
Compare QURE & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- CMP
- Stock Information
- Founded
- QURE 1998
- CMP 1993
- Country
- QURE Netherlands
- CMP United States
- Employees
- QURE N/A
- CMP N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- CMP Other Metals and Minerals
- Sector
- QURE Health Care
- CMP Basic Materials
- Exchange
- QURE Nasdaq
- CMP Nasdaq
- Market Cap
- QURE 866.3M
- CMP 781.2M
- IPO Year
- QURE 2007
- CMP 2003
- Fundamental
- Price
- QURE $70.00
- CMP $17.69
- Analyst Decision
- QURE Strong Buy
- CMP Hold
- Analyst Count
- QURE 12
- CMP 3
- Target Price
- QURE $69.67
- CMP $20.00
- AVG Volume (30 Days)
- QURE 2.6M
- CMP 368.2K
- Earning Date
- QURE 10-29-2025
- CMP 12-15-2025
- Dividend Yield
- QURE N/A
- CMP N/A
- EPS Growth
- QURE N/A
- CMP N/A
- EPS
- QURE N/A
- CMP N/A
- Revenue
- QURE $14,337,000.00
- CMP $1,225,200,000.00
- Revenue This Year
- QURE N/A
- CMP $12.05
- Revenue Next Year
- QURE $229.18
- CMP $4.15
- P/E Ratio
- QURE N/A
- CMP N/A
- Revenue Growth
- QURE N/A
- CMP 7.27
- 52 Week Low
- QURE $5.35
- CMP $8.60
- 52 Week High
- QURE $71.50
- CMP $22.69
- Technical
- Relative Strength Index (RSI)
- QURE 71.31
- CMP 42.61
- Support Level
- QURE $58.05
- CMP $17.54
- Resistance Level
- QURE $64.75
- CMP $18.91
- Average True Range (ATR)
- QURE 4.18
- CMP 0.91
- MACD
- QURE -0.71
- CMP -0.12
- Stochastic Oscillator
- QURE 89.18
- CMP 18.81
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.